No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.5x · 10Y median 2.7x · 13th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T16:56:29.869Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T16:56:29.869Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T16:56:29.869Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T16:56:29.869Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T16:56:29.869Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T16:56:29.869Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T16:56:29.869Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Definitive Healthcare Corp. (DH) stock was $1.00 as of Oct 6, 2026, 12:54 PM EDT, up 1.32% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -71.0% · 3-year avg -48.8%/yr · 5-year avg -52.5%/yr
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S.
Medical - Healthcare Information Services · Framingham, MA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
0.04
Revenue Est.
$54.57M
Last Quarter Results
EPS
$0.05
vs Estimate
$0.04
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1DH | $105.44M | $1.00 | +1.32% | -70.99% | -52.54% | N/A | N/A |
| 2ANIX | $104.96M | $3.08 | +4.58% | -9.74% | -8.26% | -4.65% | vs DH |
| 3PLYX | $104.68M | $2.10 | +1.45% | N/A | N/A | N/A | vs DH |
| 4CPIX | $106.23M | $7.09 | N/A | +172.53% | +25.62% | +5.52% | vs DH |
| 5IMUX | $107.47M | $7.89 | -2.23% | -17.41% | -35.70% | -43.80% | vs DH |
| 6CRBP | $107.83M | $5.82 | -0.51% | -60.38% | -28.32% | -31.74% | vs DH |
forward FY estimate
5.13
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$55.20M
vs Estimate
$55.47M
Consensus Rating
Based on 5 analysts
Average Price Target
$1.90
+90.2% upside
Low
$1.00
Current
$1.00
High
$3.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.04 | $0.04 | $0.04 | 5 |
| Quarter ending Dec 2026 | $0.03 | $0.04 | $0.04 | 5 |
| Quarter ending Mar 2027 | $0.05 | $0.05 | $0.05 | 3 |
| Quarter ending Jun 2027 | $0.05 | $0.05 | $0.05 | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.19 | $0.19 | $0.20 | 5 |
| FY 2027 | $0.12 | $0.19 | $0.22 | 5 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $54.36M | $54.57M | $54.82M | 4 |
| Quarter ending Dec 2026 | $55.38M | $55.60M | $55.71M | 4 |
| Quarter ending Mar 2027 | $55.62M | $55.88M | $56.24M | 2 |
| Quarter ending Jun 2027 | $55.33M | $55.59M | $55.95M | 2 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $220.98M | $221.23M | $221.58M | 5 |
| FY 2027 | $218.08M | $221.07M | $225.07M | 5 |
